Open Actively Recruiting

Noninvasive Biomarkers for Detecting Acute Allograft Rejection After Intestinal Transplantation: Investigation of a Novel Peptide, REG3A

About

Brief Summary

This study has not yet been registered on ClinicalTrials.gov, which is currently a pre-requisite for display of detailed eligibility criteria.

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Share:
Study Stats
Protocol No.
22-001448
Category
GI Disorders
Immune System/Transplant Related Disorders
Contact
Steven Stokes
Location
  • UCLA Westwood